Jeffrey Sevigny
Technik-/Wissenschafts-/F&E-Leiter bei PREVAIL THERAPEUTICS INC.
Profil
Jeffrey Sevigny is currently the Chief Medical Officer at Prevail Therapeutics, Inc. He previously worked as the Senior Director of Clinical Development at Biogen, Inc. from 2010 to 2016.
He also served as the Vice President and Head of Translational Medicine at F.
Hoffmann-La Roche Ltd.
Additionally, he held academic positions as an Assistant Professor at both Albert Einstein College of Medicine, Inc. and Columbia University College of Physicians & Surgeons.
Sevigny has also served as the Chairman of the Research Roundtable at the Alzheimer's Association.
He holds an undergraduate degree from Bowdoin College and a doctorate from Tufts University School of Medicine.
Sevigny is currently employed at Prevail Therapeutics, Inc. as the Chief Medical Officer.
Aktive Positionen von Jeffrey Sevigny
| Unternehmen | Position | Beginn |
|---|---|---|
| PREVAIL THERAPEUTICS INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2018 |
Ehemalige bekannte Positionen von Jeffrey Sevigny
| Unternehmen | Position | Ende |
|---|---|---|
| ACUMEN PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 12.08.2022 |
| BIOGEN INC. | Corporate Officer/Principal | 01.01.2016 |
Alzheimer’s Association
 Alzheimer’s Association Miscellaneous Commercial ServicesCommercial Services The Alzheimer's Association is a non-profit organization based in Chicago, IL and has subsidiaries in the United States. The non-profit company provides information and resources for Alzheimer's and other dementias. Joanne Pike has been the CEO of the company since 2021. | Corporate Officer/Principal | - |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | - |
| Albert Einstein College of Medicine, Inc. | Corporate Officer/Principal | - |
Ausbildung von Jeffrey Sevigny
| Tufts University School of Medicine | Doctorate Degree |
| Bowdoin College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BIOGEN INC. | Health Technology |
| ACUMEN PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Prevail Therapeutics, Inc.
 Prevail Therapeutics, Inc. BiotechnologyHealth Technology Prevail Therapeutics, Inc. develops therapeutics for neurodegenerative diseases. The firm engages in the research and development of novel biologic gene therapies to treat Parkinson's disease and other neurodegenerative diseases. The company was founded by Asa Abeliovich on July 6, 2017 and is headquartered in New York, NY. | Health Technology |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Health Technology |
Alzheimer’s Association
Alzheimer’s Association Miscellaneous Commercial ServicesCommercial Services The Alzheimer's Association is a non-profit organization based in Chicago, IL and has subsidiaries in the United States. The non-profit company provides information and resources for Alzheimer's and other dementias. Joanne Pike has been the CEO of the company since 2021. | Commercial Services |
